guest ::
| Home > Publications database > RhoA regulates translation of the Nogo-A decoy SPARC in white matter-invading glioblastomas > print |
| Home > Publications database > RhoA regulates translation of the Nogo-A decoy SPARC in white matter-invading glioblastomas > print |
| 001 | 866069 | ||
| 005 | 20240625095115.0 | ||
| 024 | 7 | _ | |a 10.1007/s00401-019-02021-z |2 doi |
| 024 | 7 | _ | |a 0001-6322 |2 ISSN |
| 024 | 7 | _ | |a 1432-0533 |2 ISSN |
| 024 | 7 | _ | |a 2128/23212 |2 Handle |
| 024 | 7 | _ | |a altmetric:60082153 |2 altmetric |
| 024 | 7 | _ | |a pmid:31062076 |2 pmid |
| 024 | 7 | _ | |a WOS:000477645900008 |2 WOS |
| 037 | _ | _ | |a FZJ-2019-05308 |
| 082 | _ | _ | |a 610 |
| 100 | 1 | _ | |a Wirthschaft, Peter |0 0000-0002-3099-0047 |b 0 |
| 245 | _ | _ | |a RhoA regulates translation of the Nogo-A decoy SPARC in white matter-invading glioblastomas |
| 260 | _ | _ | |a Heidelberg |c 2019 |b Springer |
| 336 | 7 | _ | |a article |2 DRIVER |
| 336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
| 336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1573141179_2205 |2 PUB:(DE-HGF) |
| 336 | 7 | _ | |a ARTICLE |2 BibTeX |
| 336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
| 336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
| 520 | _ | _ | |a Glioblastomas strongly invade the brain by infiltrating into the white matter along myelinated nerve fiber tracts even though the myelin protein Nogo-A prevents cell migration by activating inhibitory RhoA signaling. The mechanisms behind this long-known phenomenon remained elusive so far, precluding a targeted therapeutic intervention. This study demonstrates that the prevalent activation of AKT in gliomas increases the ER protein-folding capacity and enables tumor cells to utilize a side effect of RhoA activation: the perturbation of the IRE1α-mediated decay of SPARC mRNA. Once translation is initiated, glioblastoma cells rapidly secrete SPARC to block Nogo-A from inhibiting migration via RhoA. By advanced ultramicroscopy for studying single-cell invasion in whole, undissected mouse brains, we show that gliomas require SPARC for invading into white matter structures. SPARC depletion reduces tumor dissemination that significantly prolongs survival and improves response to cytostatic therapy. Our finding of a novel RhoA-IRE1 axis provides a druggable target for interfering with SPARC production and underscores its therapeutic value. |
| 536 | _ | _ | |a 572 - (Dys-)function and Plasticity (POF3-572) |0 G:(DE-HGF)POF3-572 |c POF3-572 |f POF III |x 0 |
| 536 | _ | _ | |a 511 - Computational Science and Mathematical Methods (POF3-511) |0 G:(DE-HGF)POF3-511 |c POF3-511 |f POF III |x 1 |
| 588 | _ | _ | |a Dataset connected to CrossRef |
| 700 | 1 | _ | |a Bode, Julia |0 P:(DE-Juel1)176202 |b 1 |
| 700 | 1 | _ | |a Soni, Himanshu |0 P:(DE-HGF)0 |b 2 |
| 700 | 1 | _ | |a Dietrich, Fabio |0 P:(DE-HGF)0 |b 3 |
| 700 | 1 | _ | |a Krüwel, Thomas |0 P:(DE-HGF)0 |b 4 |
| 700 | 1 | _ | |a Fischer, Bernd |0 P:(DE-HGF)0 |b 5 |
| 700 | 1 | _ | |a Knobbe-Thomsen, Christiane B. |0 P:(DE-HGF)0 |b 6 |
| 700 | 1 | _ | |a Rossetti, Giulia |0 P:(DE-Juel1)145921 |b 7 |u fzj |
| 700 | 1 | _ | |a Hentschel, Andreas |0 P:(DE-HGF)0 |b 8 |
| 700 | 1 | _ | |a Mack, Norman |0 P:(DE-HGF)0 |b 9 |
| 700 | 1 | _ | |a Schönig, Kai |0 P:(DE-HGF)0 |b 10 |
| 700 | 1 | _ | |a Breckwoldt, Michael O. |0 P:(DE-HGF)0 |b 11 |
| 700 | 1 | _ | |a Schmandke, André |0 P:(DE-HGF)0 |b 12 |
| 700 | 1 | _ | |a Pusch, Stefan |0 P:(DE-HGF)0 |b 13 |
| 700 | 1 | _ | |a Medenbach, Jan |0 P:(DE-HGF)0 |b 14 |
| 700 | 1 | _ | |a Bendszus, Martin |0 P:(DE-HGF)0 |b 15 |
| 700 | 1 | _ | |a Schwab, Martin E. |0 P:(DE-HGF)0 |b 16 |
| 700 | 1 | _ | |a von Deimling, Andreas |0 P:(DE-HGF)0 |b 17 |
| 700 | 1 | _ | |a Kool, Marcel |0 P:(DE-HGF)0 |b 18 |
| 700 | 1 | _ | |a Herold-Mende, Christel |0 P:(DE-HGF)0 |b 19 |
| 700 | 1 | _ | |a Reifenberger, Guido |0 P:(DE-HGF)0 |b 20 |
| 700 | 1 | _ | |a Ahrends, Robert |0 P:(DE-HGF)0 |b 21 |
| 700 | 1 | _ | |a Tews, Björn |0 P:(DE-HGF)0 |b 22 |e Corresponding author |
| 773 | _ | _ | |a 10.1007/s00401-019-02021-z |g Vol. 138, no. 2, p. 275 - 293 |0 PERI:(DE-600)1458410-4 |n 2 |p 275 - 293 |t Acta neuropathologica |v 138 |y 2019 |x 1432-0533 |
| 856 | 4 | _ | |u https://juser.fz-juelich.de/record/866069/files/Wirthschaft2019_Article_RhoARegulatesTranslationOfTheN.pdf |y OpenAccess |
| 856 | 4 | _ | |u https://juser.fz-juelich.de/record/866069/files/Wirthschaft2019_Article_RhoARegulatesTranslationOfTheN.pdf?subformat=pdfa |x pdfa |y OpenAccess |
| 909 | C | O | |o oai:juser.fz-juelich.de:866069 |p openaire |p open_access |p VDB |p driver |p dnbdelivery |
| 910 | 1 | _ | |a Forschungszentrum Jülich |0 I:(DE-588b)5008462-8 |k FZJ |b 7 |6 P:(DE-Juel1)145921 |
| 913 | 1 | _ | |a DE-HGF |b Key Technologies |l Decoding the Human Brain |1 G:(DE-HGF)POF3-570 |0 G:(DE-HGF)POF3-572 |2 G:(DE-HGF)POF3-500 |v (Dys-)function and Plasticity |x 0 |4 G:(DE-HGF)POF |3 G:(DE-HGF)POF3 |
| 913 | 1 | _ | |a DE-HGF |b Key Technologies |1 G:(DE-HGF)POF3-510 |0 G:(DE-HGF)POF3-511 |2 G:(DE-HGF)POF3-500 |v Computational Science and Mathematical Methods |x 1 |4 G:(DE-HGF)POF |3 G:(DE-HGF)POF3 |l Supercomputing & Big Data |
| 914 | 1 | _ | |y 2019 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1030 |2 StatID |b Current Contents - Life Sciences |
| 915 | _ | _ | |a Creative Commons Attribution CC BY 4.0 |0 LIC:(DE-HGF)CCBY4 |2 HGFVOC |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0600 |2 StatID |b Ebsco Academic Search |
| 915 | _ | _ | |a IF >= 15 |0 StatID:(DE-HGF)9915 |2 StatID |b ACTA NEUROPATHOL : 2017 |
| 915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b ACTA NEUROPATHOL : 2017 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0110 |2 StatID |b Science Citation Index |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0111 |2 StatID |b Science Citation Index Expanded |
| 915 | _ | _ | |a OpenAccess |0 StatID:(DE-HGF)0510 |2 StatID |
| 915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b ASC |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0310 |2 StatID |b NCBI Molecular Biology Database |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |
| 915 | _ | _ | |a Nationallizenz |0 StatID:(DE-HGF)0420 |2 StatID |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |
| 920 | _ | _ | |l yes |
| 920 | 1 | _ | |0 I:(DE-Juel1)IAS-5-20120330 |k IAS-5 |l Computational Biomedicine |x 0 |
| 920 | 1 | _ | |0 I:(DE-Juel1)INM-9-20140121 |k INM-9 |l Computational Biomedicine |x 1 |
| 920 | 1 | _ | |0 I:(DE-Juel1)JSC-20090406 |k JSC |l Jülich Supercomputing Center |x 2 |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a I:(DE-Juel1)IAS-5-20120330 |
| 980 | _ | _ | |a I:(DE-Juel1)INM-9-20140121 |
| 980 | _ | _ | |a I:(DE-Juel1)JSC-20090406 |
| 980 | _ | _ | |a UNRESTRICTED |
| 980 | 1 | _ | |a FullTexts |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|